Study | Country | Ethnicity | Sample size | Source of patients | Diagnostic criteria | Case | Control | HWE | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
rs35767 | CC | CT | TT | CC | CT | TT | Â | |||||
 Fan, 2017 | China | Chinese | 346/346 | Both gender | WHO | 154 | 163 | 29 | 152 | 157 | 37 | 0.932 |
 Li, 2014 | China | Chinese | 216/220 | PMOP women | WHO | 95 | 94 | 27 | 114 | 89 | 17 | 0.998 |
 Li, 2015 | China | Chinese | 485/485 | PMOP women | WHO | 202 | 210 | 74 | 238 | 201 | 46 | 0.932 |
 Liu, 2017 | China | Chinese | 320/320 | Both gender | WHO | 152 | 136 | 32 | 156 | 131 | 33 | 0.781 |
 Wei, 2015 | China | Chinese | 272/272 | PMOP women | WHO | 124 | 118 | 30 | 132 | 116 | 24 | 0.979 |
 Zhang, 2015 | China | Chinese | 428/428 | Both gender | WHO | 182 | 193 | 53 | 216 | 186 | 26 | 0.233 |
rs2288377 | AA | AT | TT | AA | AT | TT | Â | |||||
 Fan, 2017 | China | Chinese | 346/346 | Both gender | WHO | 118 | 171 | 57 | 164 | 160 | 22 | 0.113 |
 Li, 2014 | China | Chinese | 216/220 | PMOP women | WHO | 182 | 21 | 13 | 189 | 21 | 10 | < 0.001 |
 Li, 2015 | China | Chinese | 485/485 | PMOP women | WHO | 396 | 52 | 36 | 413 | 45 | 27 | < 0.001 |
 Liu, 2017 | China | Chinese | 320/320 | Both gender | WHO | 125 | 145 | 50 | 157 | 138 | 25 | 0.781 |
 Zhang, 2015 | China | Chinese | 428/428 | Both gender | WHO | 349 | 44 | 35 | 365 | 40 | 23 | < 0.001 |
rs5742612 | Â | Â | Â | Â | Â | Â | Â | |||||
 Fan, 2017 | China | Chinese | 346/346 | Both gender | WHO | 298 | 30 | 18 | 301 | 35 | 10 | < 0.001 |
 Li, 2014 | China | Chinese | 216/220 | PMOP women | WHO | 178 | 21 | 17 | 183 | 21 | 16 | < 0.001 |
 Li, 2015 | China | Chinese | 485/485 | PMOP women | WHO | 389 | 55 | 41 | 400 | 50 | 35 | < 0.001 |
 Liu, 2017 | China | Chinese | 320/320 | Both gender | WHO | 264 | 33 | 23 | 245 | 69 | 6 | 0.907 |
 Zhang, 2015 | China | Chinese | 428/428 | Both gender | WHO | 336 | 48 | 44 | 346 | 42 | 41 | < 0.001 |